According to these results, the PFS was significantly shorter in BRCA wild type group with PARP expression on tumor tissue (PFS 10.7 months, IQR: 6.3–13.9 months, p = 0.0001), in this group, the shortest overall survival could be experienced (OS 47.2 months) (Figure 1E,F). The gene discussed is PARP1; the disease is neoplasm.